15(S)-Fluprostenol structure
|
Common Name | 15(S)-Fluprostenol | ||
|---|---|---|---|---|
| CAS Number | 54276-24-3 | Molecular Weight | 458.468 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 608.0±55.0 °C at 760 mmHg | |
| Molecular Formula | C23H29F3O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 321.5±31.5 °C | |
Use of 15(S)-Fluprostenol15(S)-fluprostenol is less active as an FP agonist than 15(R)-fluprostenol. The biology of 15(S)-fluprostenol has not been widely studied. |
| Name | (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid |
|---|---|
| Synonym | More Synonyms |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 608.0±55.0 °C at 760 mmHg |
| Molecular Formula | C23H29F3O6 |
| Molecular Weight | 458.468 |
| Flash Point | 321.5±31.5 °C |
| Exact Mass | 458.191620 |
| PSA | 107.22000 |
| LogP | 2.55 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.575 |
| (+/-)16-(M-TRIFLUOROMETHYLPHENOXY)-TETRANOR-PROSTAGLANDIN F2ALPHA |
| (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(1E,3S)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid |
| (Z)-7-(3,5-dihydroxy-2-((E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-enyl)cyclopentyl)hept-5-enoic acid |
| (5Z)-rel-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid |
| FLUPROSTENOL,ETHANOL SOLUTION |
| (+/-)-16-(3-TRIFLUOROMETHYLPHENOXY)TETRANORPROSTAGLANDIN F2ALPHA |
| Fluprostenol |
| 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-, (5Z)- |
| (+/-)-9ALPHA,11ALPHA,15R-TRIHYDROXY-16-(3-(TRIFLUOROMETHYL)PHENOXY)-17,18,19,20-TETRANORPROSTA 5Z,13E-DIEN-1-OIC ACID |